The report will be delivered in 2-3 business days.

AI In Pharma Global Market Report 2021 - By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction), COVID-19 Growth And Change

aboutimg
Purchase Options
Request Sample
Request For Discount
FAQ
Infoimg

Starting Price : $4000.00 | Pages : 175 | Published : February 2021 | SKU CODE : h004 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The artificial intelligence (AI) in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by artificial intelligence (AI) companies, which are applying in the pharmaceutical industry. Only goods and services traded between entities or sold to end consumers are included.

The artificial intelligence (AI) in pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, deep learning; by drug type into small molecule, large molecules; by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

The global AI in pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 at a compound annual growth rate (CAGR) of 39%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.94 billion in 2025 at a CAGR of 47%.

The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in the pharmaceutical market. To bring a new drug to the market takes on an average 10–15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs. For instance, in January 2020, Pfizer, an American pharmaceutical company, tied up with a biotech startup Insilico Medicine to identify drug targets. With AI tools Pfizer can speed up drug discovery and reduce drug development costs in the drug development processes. Thus, increasing the adoption of AI for clinical trials research is driving AI in the pharma market.

Lack of skilled professionals may hamper the growth of artificial intelligence in the pharma market. In 2019, Indeed.com revealed that AI job postings increased 29.1% over the last year and yet, with no uncertainty due to the AI skills gap, searches for AI-related roles decreased by 14.5% over the same period. The shortage of AI skills is seen as a major barrier to the pace of technology’s adoption. In fact, 56% of senior AI professionals thought that a lack of additional, qualified AI workers was the single most important hurdle to be overcome in terms of obtaining the necessary level of AI implementation beyond business operations. Therefore, the lack of skilled professionals may hamper the growth of AI in the pharma market.

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in the pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization and process automation. For instance, in September 2019, Novartis and Microsoft announced a multiyear alliance that will leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized. Further, Novartis also established an AI Innovation Lab to empower associates to use AI across their business. Therefore, companies operating in the market are continuously focusing on introducing new technologies to survive in the AI in the pharma market.

In November 2018, Cyclica, a Canadian biotechnology company that leverages AI and computational biophysics to decentralize drug discovery collaborated with Bayer on drug discovery programs. These companies will increase drug discovery applications by increasing intelligence into the polypharmacological outlines of small molecules while further developing Cyclica’s integrated system of licensing technologies. Bayer, a German multinational pharmaceutical company, includes human and veterinary pharmaceuticals, agricultural chemicals, seeds, and biotechnology products.

The major players covered in the global AI in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise Inc., Exscientia, Cyclica, NVIDIA Corporation, XtalPi Inc., BenevolentAI, Cloud Pharmaceuticals Inc, BERG LLC, Bayer, Pfizer, Recursion Pharmaceuticals Inc., Bristol-Myers Squibb.

The countries covered in the global AI in pharma market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

North America was the largest region in the AI in pharma market in 2020. The regions covered in the global AI in pharma market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global AI in pharma market is segmented -

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

    Table Of Contents

    1. Executive Summary

    2. AI in Pharma

    Market Characteristics

    3. AI in Pharma

    Market Trends And Strategies

    4. Impact Of COVID-19 On AI in Pharma

    5. AI in Pharma

    Market Size And Growth

    5.1. Global AI in Pharma

    Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global AI in Pharma

    Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. AI in Pharma

    Market Segmentation

    6.1. Global AI in Pharma

    Market, Segmentation Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Context-Aware Processing

    Natural Language Processing

    Querying Method

    Deep Learning

    6.2. Global AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Small Molecule

    Large Molecules

    6.3. Global AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Diagnosis

    Clinical Trial Research

    Drug Discovery

    Research and Development

    Epidemic Prediction

    7. AI in Pharma

    Market Regional And Country Analysis

    7.1. Global AI in Pharma

    Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global AI in Pharma

    Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific AI in Pharma

    Market

    8.1. Asia-Pacific AI in Pharma

    Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China AI in Pharma

    Market

    9.1. China AI in Pharma

    Market Overview

    9.2. China AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India AI in Pharma

    Market

    10.1. India AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan AI in Pharma

    Market

    11.1. Japan AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia AI in Pharma

    Market

    12.1. Australia AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia AI in Pharma

    Market

    13.1. Indonesia AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea AI in Pharma

    Market

    14.1. South Korea AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe AI in Pharma

    Market

    15.1. Western Europe AI in Pharma

    Market Overview

    15.2. Western Europe AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK AI in Pharma

    Market

    16.1. UK AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany AI in Pharma

    Market

    17.1. Germany AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France AI in Pharma

    Market

    18.4. France AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe AI in Pharma

    Market

    19.1. Eastern Europe AI in Pharma

    Market Overview

    19.2. Eastern Europe AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia AI in Pharma

    Market

    20.1. Russia AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America AI in Pharma

    Market

    21.1. North America AI in Pharma

    Market Overview

    21.2. North America AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA AI in Pharma

    Market

    22.1. USA AI in Pharma

    Market Overview

    22.2. USA AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America AI in Pharma

    Market

    23.1. South America AI in Pharma

    Market Overview

    23.2. South America AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil AI in Pharma

    Market

    24.1. Brazil AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East AI in Pharma

    Market

    25.1. Middle East AI in Pharma

    Market Overview

    25.2. Middle East AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa AI in Pharma

    Market

    26.1. Africa AI in Pharma

    Market Overview

    26.2. Africa AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. AI in Pharma

    Market Competitive Landscape And Company Profiles

    27.1. AI in Pharma

    Market Competitive Landscape

    27.2. AI in Pharma

    Market Company Profiles

    27.2.1. Novartis

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. IBM Watson

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Microsoft Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. GNS Healthcare.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The AI in Pharma

    Market

    29. AI in Pharma

    Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global AI in Pharma
  • Market, Segmentation Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global AI in Pharma
  • Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global AI in Pharma
  • Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Novartis Financial Performance
  • Table 47: IBM Watson Financial Performance
  • Table 48: Microsoft Corporation Financial Performance
  • Table 49: Merck Financial Performance
  • Table 50: GNS Healthcare. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global AI in Pharma
  • Market, Segmentation Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global AI in Pharma
  • Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global AI in Pharma
  • Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Novartis Financial Performance
  • Figure 47: IBM Watson Financial Performance
  • Figure 48: Microsoft Corporation Financial Performance
  • Figure 49: Merck Financial Performance
  • Figure 50: GNS Healthcare. Financial Performance
Global Internet Of Things (IoT) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Video Surveillance As A Service (VSaaS) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Productivity Software Publishing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Data Center Colocation Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pipeline Safety Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Smart Workplace Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Printer Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Platform as a service (PaaS) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Database Software Market 2021 - By Product Type (Database Maintenance Management, Database Operation Management), By End User (BFSI, IT & Telecom, Media & Entertainment, Healthcare, Others), By Type Of Deployment (Cloud, On-Premise), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Big Data And Analytics Market 2021 - By Analytics Tools (Dashboard & Data Visualization, Self-Service Tools, Data Mining & Warehousing, Reporting), By Deployment Mode (On-Premise, Cloud), By End Use Industry (BFSI, Retail, Manufacturing, IT and Telecom, Government, Healthcare, Utility), By Application (Customer Analytics, Supply Chain Analytics, Marketing Analytics, Pricing Analytics, Spatial Analytics, Workforce Analytics, Risk & Credit Analytics, Transportation Analytics), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Business Processes Outsourcing Market - By Type (Crm Bpo, Hro Bpo, F&A Bpo, And Other Bpo Services), Drivers And Restraints, By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Video Game Software Market - By Type (Browser Games, PC Games, Smart Phone/Tablet Games, Console Games), By Genre (Action, Shooter, Adventure, Role Playing, Strategy, Fighting, Sports, Racing, Others), By Type Of Transaction (Physical, Online/ Microtransaction, Digital), And By Region, Opportunities And Strategies - Global Video Game Software Market Forecast To 2030
View Report
5G Infrastructure Equipment Market - By Communication Infrastructure (Small Cell, Macro Cell, Radio Access Network (RAN), Distributed Antenna System (DAS)), By Type of Network Technology (Software Defined Networking (SDN), Network Function Virtualization (NFV), Mobile Edge Computing (MEC), Fog Computing (FC)), And By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Browser Games Market - By Type (Pay-to- Play, Free-to-Play, Pay-in-Play), And By Region, Major Players, Opportunities And Strategies - Global Browser Games Market Forecast To 2030
View Report
Cloud Services Market - By Segments (Infrastructure As A Services (Iaas), Platform As A Services (Paas), Software As A Service (Saas), Business Process As A Services (Bpaas)), By Country, And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Internet Of Things (IoT) Market - By Platform (Device Management, Application Management, Network Management), By End-Use Industry (BFSI, Retail, Government, Healthcare, Manufacturing, Transportation,IT and Telecom, Others), By Application (Building And Home Automation, Smart Energy And Utilities, Smart Manufacturing, Connected Logistics, Smart Retail , Smart Mobility And Transportation, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)